JNJ

Johnson & Johnson Third Quarter Earnings Sneak Peek
Yahoo/Wall St. Cheat Sheet
Thu, 10/13/11 - 10:57 am
earnings
JNJ
Amgen
Abbott Laboratories
Boston Scientific
J&J Didn’t Warn Levaquin Riskier Than Rivals, Lawyer Argues
Bloomberg
Thu, 10/13/11 - 10:53 am
JNJ
antibiotics
Levaquin
Ortho-McNeil-Janssen
Johnson & Johnson: Dividend Stock Analysis
Seeking Alpha
Mon, 10/10/11 - 10:59 am
JNJ
dividends
Seeking Diversification Through Drug Company Dividend Stocks
Seeking Alpha
Thu, 10/6/11 - 12:00 pm
dividends
JNJ
Pfizer
Novartis
GSK
Merck
Sanofi
Abbott Laboratories
AstraZeneca
Amgen
Eli Lilly
Bristol-Myers Squibb
Millennium withdraws cancer drug application
Bizjournals.com
Thu, 10/6/11 - 11:56 am
Millennium
Velcade
follicular lymphoma
JNJ
Brand Power To The People: J&J Takes Lead In Forbes Ranking
Forbes
Thu, 10/6/11 - 09:22 am
JNJ
branding
Rivaroxaban Roundup: NEJM Perspective on FDA Panel, ATLAS-ACS Will Be an AHA Late-Breaker
Forbes
Thu, 10/6/11 - 09:18 am
FDA
rivaroxaban
Xarelto
Bayer
JNJ
J&J To Pay $48M To Man Hurt By Motrin
Pharmalot
Wed, 10/5/11 - 10:57 am
Motrin
JNJ
settlements
J&J Directors Win Dismissal of Investor ‘Red Flags’ Suit
Bloomberg
Wed, 10/5/11 - 09:56 am
JNJ
investors
recalls
Omnicare
Valeant Pharma Offer Tops Paladin's
Yahoo/Zacks.com
Fri, 09/30/11 - 09:29 am
Valeant Pharmaceuticals
Paladin
Cephalon
JNJ
Dermik
Sanofi
Rivaroxaban Meets Primary Endpoint in ATLAS ACS TIMI 51
Forbes
Fri, 09/30/11 - 09:26 am
rivaroxaban
JNJ
Xarelto
acute coronary syndrome
Bayer
Are HIV Drugmakers Doomed?
Motley Fool
Fri, 09/30/11 - 09:25 am
HIV
Pfizer
Merck
JNJ
Bristol-Myers Squibb
Sangamo BioSciences
Gilead
Abbott Laboratories
Merck sells stake in OTC drug venture to J&J unit
Marketwatch
Wed, 09/28/11 - 06:07 pm
OTC
Merck
JNJ
McNeil
J&J company Ethicon Endo-Surgery buys medical device firm SterilMed for undisclosed terms
Yahoo/AP
Wed, 09/28/11 - 11:32 am
JNJ
Ethicon-Endo Surgery
M&A
SterilMed
J&J's Doxil Woes Show Shortages Aren't Easily Fixed
Motley Fool
Tue, 09/27/11 - 07:26 pm
Doxil
JNJ
drug shortages
cancer
Johnson & Johnson's Xarelto Not a Cure for Pipeline Concerns
Seeking Alpha
Sun, 09/25/11 - 01:05 pm
JNJ
Xarelto
Healthcare: 8 Safe Bets For Dividends And Great Returns
Seeking Alpha
Sat, 09/24/11 - 12:52 pm
Abbot
Merck
Eli Lilly
JNJ
Bristol-Myers Squibb
Novartis
Pfizer
AstraZeneca
J&J Recall Watch: Eprex Anemia Drug Pulled on Potency Worries
WSJ Online
Fri, 09/23/11 - 12:01 pm
Eprex
anemia
recalls
JNJ
Top High-Dividend Healthcare Stocks
Seeking Alpha
Thu, 09/22/11 - 02:20 pm
dividends
Abbott Laboratories
AstraZeneca
Bristol-Myers Squibb
GSK
JNJ
Eli Lilly
Merck
Novartis
Pfizer
Sanofi
J&J Begins to Rebound from Recalls
Barron's
Wed, 09/21/11 - 11:13 pm
recalls
JNJ

Pages